SGRY - Surgery Partners, Inc.
Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
I initiate coverage of Surgery Partners with a Buy, citing positives relating to the Idaho Falls divestiture. SGRY's asset sale reduces leverage, improves cash flow, and shifts payor mix away from Medicaid. That also simplifies its business and boosts its valuation appeal as a short-stay surgical pure-play. I see significant upside from the $60B inpatient-to-outpatient migration, supported by robust practitioner recruitment and disciplined acquisition strategy.
BRENTWOOD, Tenn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced it has completed the previously announced sale of its ownership interests in its Idaho Falls facilities to Intermountain Health.
The purchase was valued at approximately $161,000. DeLuca's total position now consists of 68,093 shares.
BlackRock Inc. acquired a new position in shares of Surgery Partners, Inc. (NASDAQ: SGRY) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 6,241,503 shares of the company's stock, valued at approximately $104,857,000. BlackRock Inc. owned 4.77% of Surgery Partners at the
Weak July jobs data raises hopes for Fed easing, putting health care and select retail ETFs and stocks in focus.
Surgery Partners, Inc. (NASDAQ: SGRY - Get Free Report) shares gapped up prior to trading on Monday following a better than expected earnings announcement. The stock had previously closed at $15.53, but opened at $16.46. Surgery Partners shares last traded at $15.9050, with a volume of 173,693 shares. The company reported $0.10 earnings per share (EPS)
Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript
Surgery Partners NASDAQ: SGRY reported second-quarter 2026 revenue and adjusted EBITDA above its internal expectations, while reaffirming its full-year outlook ahead of the anticipated sale of its Idaho Falls market operations to Intermountain Health.
Surgery Partners (SGRY) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.17 per share a year ago.
On July 31, 2026, Surgery Partners Inc (SGRY) shares fell 3.1% to a current price of $15.38. This decline comes amid a 52-week trading range of $11.41 to $24.10
Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Surgery Partners, Inc. (NASDAQ:SGRY) stock is trading higher on Friday as the company announced a significant transaction involving the sale of its ownership interests in Idaho Falls facilities to Intermountain Health.
BRENTWOOD, Tenn., July 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced it, along with its existing partner Intermountain Health, has placed into escrow signature pages to definitive agreements, pursuant to which Surgery Partners would sell its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health.
Surgery Partners (SGRY) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Surgery Partners (SGRY) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
The average of price targets set by Wall Street analysts indicates a potential upside of 26.1% in Surgery Partners (SGRY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Surgery Partners operates a massive nationwide network of outpatient surgical facilities and hospitals. Viemed Healthcare is a high-growth specialist focusing on home-based respiratory care and disease management.
Surgery Partners, Inc. (SGRY) Q1 2026 Earnings Call Transcript
Surgery Partners (SGRY) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to earnings of $0.04 per share a year ago.